SZ-117, a monoclonal antibody against matrix metalloproteinase-2 inhibits tumor cell-mediated angiogenesis

Hybridoma

Volumn 31, Issue 1, 2012, Pages 63-67

  Bu, Zibin ^a,b,c   Pan, Yanyan ^a,b,c   Shang, Bingxue ^a,b,c   Cao, Zhifei ^a,b,c   Zhou, Quansheng ^a,b,c   Ruan, Changgeng ^a,b,c  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b BEIJING HOSPITAL   (China)

^c SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GELATIN; GELATINASE A; GELATINASE B; MONOCLONAL ANTIBODY; SZ 117; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL STRAIN; CELL STRUCTURE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SARCOMA CELL; TUMOR CELL; ZYMOGRAPHY;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTIBODIES, MONOCLONAL; CELL LINE, TUMOR; ENDOTHELIUM, VASCULAR; HUMANS; HYBRIDOMAS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASE INHIBITORS; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PATHOLOGIC;

EID: 84856837798     PISSN: 15540014     EISSN: 15578348     Source Type: Journal    
DOI: 10.1089/hyb.2011.0088     Document Type: Article

References (18)

1. Ribatti D: The discovery of antiangiogenic molecules: a historical review. Curr Pharm Des 2009;15:345-352.
2. Carmeliet P, and Jain RK: Molecular mechanisms and clinical applications of angiogenesis. Nature 2011;473: 298-307.
3. Folkman J: Tumor angiogenesis: therapeutic implications. N Engl J Med 1971;285:1182-1186.
4. Presta LG, Chen H, O'Connor SJ, Chisholm V, Meng Y.G, Krummen L, Winkler M, and Ferrara N: Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Res 1997;57:4593-4599. (Pubitemid 27441066)
5. Heath VL, and Bicknell R: Anticancer strategies involving the vasculature. Nat Rev Clin Oncol 2009;l6:395-404.
6. Loges S, Mazzone M, Hohensinner P, and Carmeliet P: Silencing or fueling metastasis with VEGF inhibitors: anti-angiogenesis revisited. Cancer Cell 2009;15:167-170.
7. Ebos JM, Lee CR, Cruz-Munoz W, Bjarnason GA, Christensen JG, and Kerbel RS: Accelerated metastasis after short-term treatment with a potent inhibitor of tumor an-giogenesis. Cancer Cell 2009;15:232-239.
8. Wang R, Chadalavada K, Wilshire J, Kowalik U, Hovinga KE, Geber A, Fligelman B, Leversha M, Brennan C, and Tabar V: Glioblastoma stem-like cells give rise to tumour endothelium. Nature 2010; 468:829-833.
9. Ricci-Vitiani L, Pallini R, Biffoni M, Todaro M, Invernici G, Cenci T, Maira G, Parati EA, Stassi G, Larocca LM, and Maria RD: Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 2010;468: 824-828.
10. Kucera T, and Lammert E: Ancestral vascular tube formation and its adoption by tumors. Biol Chem 2009;390: 985-994.
11. Zhou Q, William B. K, Jin L, and Paul S: Tumor endothelial cell tube formation model for determining anti-angiogenic activity of tRNA synthetase cytokine. Methods 2008;44: 190-194.
12. Zhou Q, Kapoor M, Guo M, Belani1R, Xu X, Kiosses WB, Hanan M, Park C, Armour E, Do M-H, Nangle LA, Paul S, and Yang X-L: Orthogon of a human tRNA synthetase active site to achieve multifunctionality. Nat Struct Mol Biol 2010; 17:57-61.
13. Hu X, Shen F, Dong N, Li P, and Ruan C: Preparation and study of monoclonal antibody to matrix metalloproteinase-2. Chin J Path 2005;5:876-881.
14. Zhou Q, Zhao Y, Li P, and Ruan C: A monoclonal antibody (SZ-53) against thrombomodulin inhibits thrombin-mediated release of t-PA and PGI2 from endothelial cells. Nouv Rev Fr Hematol 1991;33:329-342.
15. Zhao Y, Dong N, Shen F, Xie L, He Y, Liu F, and Ruan C: Two novel monoclonal antibodies to VWFA3 inhibit VWF-collagen and VWF-platelet interactions. J Thromb Haemost 2007;5:1963-1970. (Pubitemid 47288956)
16. Zhou Q, Zhao J, Wildmer T, and Sims PJ: Normal hemo-stasis but defective hematopoietic response to growth factors in mice deficient in phospholipid scramblase 1. Blood 2002; 99:4030-4038. (Pubitemid 35332044)
17. Zhou Q, Ben-Efraim I, Bigcas JL, Junqueira D, Wiedmer T, and Sims PJ: Phospholipid scramblase 1 binds to the promoter region of the inositol 1,4,5-triphosphate receptor type 1 gene to enhance its expression. J Biol Chem 2005;280: 35062-35068. (Pubitemid 41504641)
18. Zhang LZ, Mei J, Qian ZK, Cai XS, Jiang Y, and Huang WD: The role of VE-cadherin in osteosarcoma cells. Pathol Oncol Res 2009;16:111-117.